Ivan Jarry: Transplanting the seamlessness of consumer health to clinical trials
Send us Fan Mail
We speak to CEO of ObvioHealth, Ivan Jarry, about how clinical trials conducted for consumer products are different from trials in pharma and biotech - and how working with these has enabled ObvioHealth to create a holistic solution for decentralised trials.
When COVID came, ObvioHealth’s platform built for consumer products was what pharma and biotech needed to continue their ongoing trials in a decentralized environment. Starting in smaller settings and building out to more complex trials created a unique value proposition of a holistic end-to-end platform.
Measurements at…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.